Fenimore Christopher R. 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Dec 9, 2025
Insider Transaction Report
Form 4
Fenimore Christopher R.
VP, Controller
Transactions
- Award
Common Stock
2025-12-05+3,027→ 19,292 total - Tax Payment
Common Stock
2025-12-08$712.94/sh−992$707,236→ 18,300 total - Award
Non-Qualified Stock Option (right to buy)
2025-12-05+14,924→ 14,924 totalExercise: $726.71Exp: 2035-12-05→ Common Stock (14,924 underlying)
Holdings
- 1,548(indirect: By 401(k))
Common Stock
- 1,897(indirect: By Trust)
Common Stock
- 25(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 5, 2027 and 50% on December 5, 2029.
- [F2]These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
- [F3]The stock option award vests in four equal annual installments, commencing one year after the date of grant.